MedPath

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

Phase 2
Completed
Conditions
Brain Tumor
Central Nervous System Tumors
Myelodysplastic Syndromes
Unspecified Childhood Solid Tumor, Protocol Specific
Myelodysplastic/Myeloproliferative Diseases
Cachexia
Leukemia
Lymphoma
Interventions
Registration Number
NCT00066248
Lead Sponsor
University of South Florida
Brief Summary

RATIONALE: Cyproheptadine and megestrol may improve appetite and help prevent weight loss in children with cancer.

PURPOSE: This phase II trial is studying how well cyproheptadine and megestrol work in improving appetite and preventing weight loss in children with cachexia caused by cancer or cancer treatment.

Detailed Description

OBJECTIVES:

* Determine the efficacy of cyproheptadine in preventing further weight loss in children with cancer or cancer treatment-related cachexia.

* Determine the efficacy of megestrol in preventing further weight loss in patients who don't respond to cyproheptadine.

* Determine how these drugs affect body protein and fat levels in these patients.

OUTLINE: Patients receive oral cyproheptadine twice daily for 4 weeks in the absence of unacceptable weight loss or toxicity. Patients that present with weight loss after 4 weeks receive oral megestrol daily for 4 weeks in the absence of unacceptable weight loss or toxicity. Patients responding to either cyproheptadine or megestrol may continue treatment at the discretion of the treating physician.

Patients are followed at 4 weeks.

PROJECTED ACCRUAL: A total of 70 patients will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Subjects that respond to Periactincyproheptadine hydrochlorideReceive 0.25mg/kg cyproheptadine hydrochloride once daily for 4 weeks. If subject responds to treatment (stable or increased weigh), go off study. If subject does not respond (loses weigh), subject will switch to10 mg/lg/day of megestrol acetate for 4 weeks.
Non-responders to Periactin- Megace Armcyproheptadine hydrochlorideReceive 0.25mg/kg cyproheptadine hydrochloride once daily for 4 weeks. If subject responds to treatment (stable or increased weigh), go off study. If subject does not respond (loses weigh), subject will switch to10 mg/lg/day of megestrol acetate for 4 weeks.
Non-responders to Periactin- Megace Armmegestrol acetateReceive 0.25mg/kg cyproheptadine hydrochloride once daily for 4 weeks. If subject responds to treatment (stable or increased weigh), go off study. If subject does not respond (loses weigh), subject will switch to10 mg/lg/day of megestrol acetate for 4 weeks.
Primary Outcome Measures
NameTimeMethod
Efficacy of study agents as measured by changes in weight at baseline, and 4 weeks after the beginning of study treatment4-8 weeks
Secondary Outcome Measures
NameTimeMethod
Effect of study agents on protein and fat levels as measured by pre-albumin and lipid profile at baseline, and 4 weeks after the beginning of study treatment4-8 weeks

Trial Locations

Locations (43)

Kaplan Cancer Center at St. Mary's Medical Center

πŸ‡ΊπŸ‡Έ

West Palm Beach, Florida, United States

Children's Hospital and Regional Medical Center - Seattle

πŸ‡ΊπŸ‡Έ

Seattle, Washington, United States

University of Florida Shands Cancer Center

πŸ‡ΊπŸ‡Έ

Gainesville, Florida, United States

Sacred Heart Cancer Center at Sacred Heart Hospital

πŸ‡ΊπŸ‡Έ

Pensacola, Florida, United States

Floating Hospital for Children at Tufts - New England Medical Center

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Children's Hospital of New Orleans

πŸ‡ΊπŸ‡Έ

New Orleans, Louisiana, United States

DeVos Children's Hospital

πŸ‡ΊπŸ‡Έ

Grand Rapids, Michigan, United States

CCOP - Beaumont

πŸ‡ΊπŸ‡Έ

Royal Oak, Michigan, United States

Tomorrows Children's Institute at Hackensack University Medical Center

πŸ‡ΊπŸ‡Έ

Hackensack, New Jersey, United States

Vermont Cancer Center at University of Vermont

πŸ‡ΊπŸ‡Έ

Burlington, Vermont, United States

Montreal Children's Hospital at McGill University Health Center

πŸ‡¨πŸ‡¦

Montreal, Quebec, Canada

St. Vincent Hospital Regional Cancer Center

πŸ‡ΊπŸ‡Έ

Green Bay, Wisconsin, United States

CHRISTUS Santa Rosa Children's Hospital

πŸ‡ΊπŸ‡Έ

San Antonio, Texas, United States

Methodist Cancer Center at Methodist Specialty and Transplant Hospital

πŸ‡ΊπŸ‡Έ

San Antonio, Texas, United States

MBCCOP - South Texas Pediatrics

πŸ‡ΊπŸ‡Έ

San Antonio, Texas, United States

Columbus Children's Hospital

πŸ‡ΊπŸ‡Έ

Columbus, Ohio, United States

University of Minnesota Cancer Center

πŸ‡ΊπŸ‡Έ

Minneapolis, Minnesota, United States

Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center

πŸ‡ΊπŸ‡Έ

Kansas City, Kansas, United States

Cancer Research Center of Hawaii

πŸ‡ΊπŸ‡Έ

Honolulu, Hawaii, United States

All Children's Hospital

πŸ‡ΊπŸ‡Έ

St. Petersburg, Florida, United States

CCOP - Scott and White Hospital

πŸ‡ΊπŸ‡Έ

Temple, Texas, United States

MBCCOP - Medical College of Georgia Cancer Center

πŸ‡ΊπŸ‡Έ

Augusta, Georgia, United States

Roswell Park Cancer Institute

πŸ‡ΊπŸ‡Έ

Buffalo, New York, United States

Children's Medical Center - Dayton

πŸ‡ΊπŸ‡Έ

Dayton, Ohio, United States

SUNY Upstate Medical University Hospital

πŸ‡ΊπŸ‡Έ

Syracuse, New York, United States

CCOP - Bay Area Tumor Institute

πŸ‡ΊπŸ‡Έ

Oakland, California, United States

Siteman Cancer Center at Barnes-Jewish Hospital

πŸ‡ΊπŸ‡Έ

Saint Louis, Missouri, United States

Children's Hospitals and Clinics of Minnesota - Minneapolis

πŸ‡ΊπŸ‡Έ

Saint Paul, Minnesota, United States

Hopital Sainte Justine

πŸ‡¨πŸ‡¦

Montreal, Quebec, Canada

Tod Children's Hospital

πŸ‡ΊπŸ‡Έ

Youngstown, Ohio, United States

Van Elslander Cancer Center at St. John Hospital and Medical Center

πŸ‡ΊπŸ‡Έ

Detroit, Michigan, United States

Legacy Emanuel Hospital and Health Center & Children's Hospital

πŸ‡ΊπŸ‡Έ

Portland, Oregon, United States

CCOP - Florida Pediatric

πŸ‡ΊπŸ‡Έ

Tampa, Florida, United States

St. Joseph's Children's Hospital of Tampa

πŸ‡ΊπŸ‡Έ

Tampa, Florida, United States

Children's Hospital & Research Center Oakland

πŸ‡ΊπŸ‡Έ

Oakland, California, United States

Children's National Medical Center

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Blumenthal Cancer Center at Carolinas Medical Center

πŸ‡ΊπŸ‡Έ

Charlotte, North Carolina, United States

Children's Hospital Medical Center of Akron

πŸ‡ΊπŸ‡Έ

Akron, Ohio, United States

Children's Hospital of Pittsburgh

πŸ‡ΊπŸ‡Έ

Pittsburgh, Pennsylvania, United States

Virginia Commonwealth University Massey Cancer Center

πŸ‡ΊπŸ‡Έ

Richmond, Virginia, United States

San Jorge Children's Hospital

πŸ‡΅πŸ‡·

Santurce, Puerto Rico

Wake Forest University Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Winston-Salem, North Carolina, United States

Nemours Children's Clinic

πŸ‡ΊπŸ‡Έ

Jacksonville, Florida, United States

Β© Copyright 2025. All Rights Reserved by MedPath